Rheumatoid Arthritis Pipeline Market Global Research Covering 222 Companies

RnRMarketResearch.com adds “Rheumatoid Arthritis – Pipeline Review, H1 2016” to its database.

Pune, India – July 28, 2016 /MarketersMedia/ —

Rheumatoid Arthritis Pipeline Market Companies Involved in Therapeutics Development are 3SBio Inc. ,4D Pharma Plc ,4SC AG ,AB Science SA ,AB2 Bio Ltd. ,AbbVie Inc. ,Ablynx NV ,ACEA Biosciences, Inc. ,Addex Therapeutics Ltd ,Advinus Therapeutics Ltd ,AlphaMab Co., Ltd ,Alteogen Inc. ,Amgen Inc. ,Amura Holdings Limited ,Anacor Pharmaceuticals, Inc. ,Applied Genetic Technologies Corporation ,ARA Healthcare Pvt. Ltd. ,Arena Pharmaceuticals, Inc. ,Arrien Pharmaceuticals, LLC ,Arthrogen BV ,Asahi Kasei Pharma Corp. ,Asana BioSciences, LLC ,Astellas Pharma Inc. ,AstraZeneca Plc ,Avexxin AS ,Axxam SpA ,BCN Peptides, S.A. ,Bio-Cancer Treatment International Limited ,BIOCAD ,Biocon Limited ,Biokine Therapeutics Ltd. ,BioLingus AG ,BioLite, Inc. ,Bionovis SA ,BioTherapeutics Inc. ,Bird Rock Bio, Inc. ,Boehringer Ingelheim GmbH ,Bone Medical Limited ,Boryung Pharmaceutical Co., Ltd. ,Bristol-Myers Squibb Company ,Can-Fite BioPharma Ltd. ,Cardax Pharmaceuticals, Inc. ,CASI Pharmaceuticals Inc. ,CEL-SCI Corporation ,Celgene Corporation ,Cellceutix Corporation ,Celltrion, Inc. ,ChemoCentryx, Inc. ,Chipscreen Biosciences Ltd ,ChironWells GmbH ,Chong Kun Dang Pharmaceutical Corp. ,CJ HealthCare Corp. ,CLL Pharma ,Clonz Biotech Private Limited ,Coherus BioSciences, Inc. ,Commence Bio, Inc. ,Compugen Ltd. ,Confluence Life Sciences, Inc. ,CSL Limited ,Cyclacel Pharmaceuticals, Inc. ,Daiichi Sankyo Company, Limited ,Diamyd Medical AB ,Domainex Limited ,Dr. Reddy’s Laboratories Limited ,Eisai Co., Ltd. ,Eli Lilly and Company ,Enceladus Pharmaceuticals BV ,Endocyte, Inc. ,Enzene Biosciences Ltd. ,Epirus Biopharmaceuticals, Inc. ,F. Hoffmann-La Roche Ltd. ,Five Prime Therapeutics, Inc. ,Fountain Biopharma Inc. ,Galapagos NV ,Gene Techno Science Co., Ltd. ,Genentech, Inc. ,Genor BioPharma Co., Ltd. ,Genosco ,Gilead Sciences, Inc. ,GlaxoSmithKline Plc ,Griffin Discoveries BV ,Han Wha Pharma Co., Ltd. ,Handok Inc. ,Hanmi Pharmaceuticals, Co. Ltd. ,Hansa Medical AB ,Hanwha Chemical Corporation ,HEC Pharm Co., Ltd. ,Hetero Drugs Limited ,HitGen LTD ,Huabo Biopharm Co., Ltd. ,Hutchison MediPharma Limited ,Idera Pharmaceuticals, Inc. ,Idogen AB ,Immune Response BioPharma, Inc. ,Immungenetics AG ,ImmunoFrontier, Inc. ,Innate Pharma S.A. ,Innovent Biologics, Inc. ,Intas Pharmaceuticals Ltd. ,ISU ABXIS Co.,Ltd. ,JHL Biotech, Inc. ,Jiangsu Hengrui Medicine Co., Ltd. ,Johnson & Johnson ,Jyant Technologies, Inc. ,Kadmon Corporation, LLC ,KAHR medical Ltd. ,Kang Stem Biotech Co., Ltd. ,Karus Therapeutics Limited ,Karyopharm Therapeutics, Inc. ,Kezar Life Sciences, Inc. ,Kineta, Inc. ,Kolltan Pharmaceuticals, Inc. ,Lead Pharma Holding B.V. ,Lexicon Pharmaceuticals, Inc. ,LG Life Science LTD. ,Lipocure Ltd. ,LSK BioPartners, Inc. ,Lupin Limited ,Mabion SA ,Mabtech Limited ,mAbxience S.A. ,MacroGenics, Inc. ,Mebiopharm Co., Ltd. ,MedAnnex Ltd ,Medestea Research & Production S.p.A. ,MediGene AG ,MedImmune, LLC ,Mesoblast Limited ,Millennium Pharmaceuticals, Inc. ,Mitsubishi Tanabe Pharma Corporation ,Modern Biosciences Plc ,ModiQuest Group ,Momenta Pharmaceuticals, Inc. ,Morphotek, Inc. ,Mycenax Biotech Inc. ,MYOS RENS Technology Inc. ,Myungmoon pharmaceutical Co., Ltd. ,NanoSmart Pharmaceuticals, Inc. ,Navigen Pharmaceuticals, Inc. ,Neovacs SA ,Nimbus Therapeutics, LLC ,Nissan Chemical Industries, Ltd. ,Novartis AG ,NovImmune SA ,Nuevolution AB ,Omeros Corporation ,Oncobiologics, Inc. ,Oncodesign SA ,OncoImmune, Inc. ,Ono Pharmaceutical Co., Ltd. ,OPKO Health, Inc. ,Opsona Therapeutics Limited ,Oscotec Inc. ,OSE Immunotherapeutics ,Panacea Biotec Limited ,Paras Biopharmaceuticals Finland Oy ,Parvus Therapeutics, Inc. ,Peptinov SAS ,Pfenex Inc. ,Pfizer Inc. ,Pharmacyclics, Inc. ,Pharmedartis GmbH ,Phenex Pharmaceuticals AG ,Philogen S.p.A. ,PLx Pharma Inc. ,Principia Biopharma Inc. ,Progenra, Inc. ,ProNoxis AB ,ProtAb Ltd ,Protagonist Therapeutics Inc. ,Protalex, Inc. ,Protalix BioTherapeutics, Inc. ,Qu Biologics Inc. ,R-Pharm ,Re-Pharm Limited ,ReceptoPharm, Inc. ,RedHill Biopharma Ltd. ,Redx Pharma Plc ,Regeneron Pharmaceuticals, Inc. ,Resverlogix Corp. ,ReveraGen BioPharma, Inc. ,Rhizen Pharmaceuticals S.A. ,Richter Gedeon Nyrt. ,Saje Pharma, LLC ,Sandoz International GmbH ,Sareum Holdings Plc ,SBI Biotech Co., Ltd. ,Selvita S.A. ,Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. ,Shanghai Henlius Biotech Co., Ltd. ,Shanghai Pharmaceutical Co., Ltd. ,Swedish Orphan Biovitrum AB ,Synovo GmbH ,Syntrix Biosystems, Inc. ,TaiwanJ Pharmaceuticals Co., Ltd. ,Takeda Pharmaceutical Company Limited ,TechnoPhage SA ,Teijin Pharma Limited ,The International Biotechnology Center (IBC) Generium ,TheraMAB LLC ,Therapeutic Proteins International, LLC ,TiGenix NV ,Toleranzia AB ,Tumorend, LLC ,TxCell SA ,U.S. Stem Cell, Inc. ,UCB S.A. ,United BioPharma, Inc. ,Vaccinex, Inc. ,Valeant Pharmaceuticals International, Inc. ,Vichem Chemie Research Ltd. ,Vicore Pharma AB ,Vida Therapeutics Inc. ,Vitae Pharmaceuticals, Inc. ,Vitaeris Inc ,Xbrane Biopharma AB ,Xencor, Inc. ,XTL Biopharmaceuticals Ltd. ,Yungjin Pharm. Co., Ltd. ,Yuyu Pharma, Inc. ,Zenyaku Kogyo Co., Ltd. ,Zydus Cadila Healthcare Limited.

Inquire more about this research report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=647177

The report provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis
• The report reviews pipeline therapeutics for Rheumatoid Arthritis by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Rheumatoid Arthritis therapeutics and enlists all their major and minor projects
• The report assesses Rheumatoid Arthritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Rheumatoid Arthritis

Reasons to buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Rheumatoid Arthritis
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/rheumatoid-arthritis-pipeline-market-global-research-covering-222-companies/125572

Release ID: 125572